Procalcitonin under Investigation as a Means of Detecting Severe Sepsis, Septic Shock and Bacteremia at Emergency Department, Rajavithi Hospital
- PMID: 27266218
Procalcitonin under Investigation as a Means of Detecting Severe Sepsis, Septic Shock and Bacteremia at Emergency Department, Rajavithi Hospital
Abstract
Background: Severe sepsis, septic shock and bacteremia are critical illnesses, and patients with these conditions require close monitoring and immediate medical treatment. Any delay in diagnosis may lead to an increase in mortality in such critically ill patients. Serum procalcitonin (PCT) has emerged as a highly accurate biomarker for differentiating sepsis from other non-infectious triggers.
Objective: In this study, we investigated the effectiveness of PCT in obtaining early diagnosis and efficient prognosis for such patients at the Emergency Department of Rajavithi Hospital.
Material and method: A prospective study was performed of 110 adult patients who attended the emergency service department between August 1 2013 and October 31 2013. The effectiveness of PCT as a specific blood test analysis tool for detecting and classifying the severity of patients with sepsis was investigated, and sensitivity, specificity, negative predictive values (NPV), positive predictive values (PPV) and positive likelihood ratio (LR+) were used to differentiate infected patients.
Results: One hundred and ten patients were enrolled and classified into 3 categories as follows: severe sepsis (n = 34, 30.9%), septic shock (n = 13, 11.8%), and bacteremia (n = 23, 20.9%). At a PCT level of ≥ 2 ng/dL, it was feasible to categorize patients as having severe sepsis (p < 0.001; RR 3.58; 95% CI 2.18-5.89), septic shock (p = 0.001; 5.73; 2.06- 15.93) or bacteremia (p < 0.001; 3.91; 1.98-7.73). Moreover, the PCT value yielded the following diagnostic performances for patients with: severe sepsis (PPV 70.8%; NPV 80.2%; LR+ 5.0; sensitivity 50.0%; specificity 90.8%); septic shock (33.3%; 94.2%; 3.6; 61.5%; 83.5%); and bacteremia (50.0%; 87.2%; 3.7; 52.2%; 86.2%).
Conclusion: PCT can be usefully employed as a promising chemical biomarker to differentiate the severity of infections in critically ill patients. Used together with clinical data, the PCT value of ≥ 2 ng/dL is efficient in categorizing such patients as having severe sepsis, septic shock or bacteremia.
Similar articles
-
The usefulness of the semiquantitative procalcitonin test kit as a guideline for starting antibiotic administration.Am J Emerg Med. 2009 Sep;27(7):859-63. doi: 10.1016/j.ajem.2008.06.021. Am J Emerg Med. 2009. PMID: 19683118
-
[Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients].Chirurgia (Bucur). 2012 Jan-Feb;107(1):71-8. Chirurgia (Bucur). 2012. PMID: 22480120 Romanian.
-
The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department.Thromb Res. 2013 Oct;132(4):471-6. doi: 10.1016/j.thromres.2013.08.011. Epub 2013 Aug 28. Thromb Res. 2013. PMID: 24035044
-
The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?Surg Infect (Larchmt). 2013 Dec;14(6):489-511. doi: 10.1089/sur.2012.028. Epub 2013 Nov 25. Surg Infect (Larchmt). 2013. PMID: 24274059 Review.
-
Update on procalcitonin measurements.Ann Lab Med. 2014 Jul;34(4):263-73. doi: 10.3343/alm.2014.34.4.263. Epub 2014 Jun 19. Ann Lab Med. 2014. PMID: 24982830 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical